Merit Medical Systems (NASDAQ:MMSI - Get Free Report) is projected to announce its earnings results after the market closes on Tuesday, February 25th. Analysts expect the company to announce earnings of $0.82 per share and revenue of $351.54 million for the quarter. Investors that wish to listen to the company's conference call can do so using this link.
Merit Medical Systems Trading Down 2.4 %
Shares of Merit Medical Systems stock traded down $2.50 during trading on Friday, hitting $103.16. The company's stock had a trading volume of 472,347 shares, compared to its average volume of 502,260. The company has a debt-to-equity ratio of 0.57, a current ratio of 5.36 and a quick ratio of 3.82. Merit Medical Systems has a 52 week low of $70.70 and a 52 week high of $111.45. The stock has a market cap of $6.01 billion, a price-to-earnings ratio of 50.57, a price-to-earnings-growth ratio of 2.36 and a beta of 0.87. The stock has a 50-day moving average price of $102.63 and a two-hundred day moving average price of $99.46.
Analysts Set New Price Targets
Several analysts recently weighed in on MMSI shares. Robert W. Baird boosted their price objective on shares of Merit Medical Systems from $107.00 to $109.00 and gave the stock an "outperform" rating in a research note on Thursday, October 31st. Barrington Research boosted their price objective on Merit Medical Systems from $114.00 to $115.00 and gave the company an "outperform" rating in a research note on Wednesday, January 29th. Piper Sandler reiterated an "overweight" rating and issued a $116.00 target price (up from $114.00) on shares of Merit Medical Systems in a report on Wednesday, January 29th. Needham & Company LLC increased their price target on Merit Medical Systems from $109.00 to $122.00 and gave the stock a "buy" rating in a report on Wednesday, January 29th. Finally, StockNews.com lowered shares of Merit Medical Systems from a "buy" rating to a "hold" rating in a research note on Sunday, November 3rd. Two investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, Merit Medical Systems has a consensus rating of "Moderate Buy" and an average price target of $109.80.
Read Our Latest Research Report on Merit Medical Systems
About Merit Medical Systems
(
Get Free Report)
Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.
See Also
Before you consider Merit Medical Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merit Medical Systems wasn't on the list.
While Merit Medical Systems currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
